Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe gastric cancer trial record is available with its study design, participant criteria, treatment plan, outcome measures, locations, and results information. The study is marked completed and is no longer recruiting.SummaryDifference54%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner announces an NIH terminology transition, saying “Super Intelligence” is replacing “Artificial Intelligence” across NIH content. It appears above the study page’s 403 error.SummaryDifference1%

- Check26 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study content with a generic site footer. This looks like an access or server issue rather than a substantive update to the trial information.SummaryDifference19%

Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.